Shah, N. N., Schneiderman, J., Kuruvilla, D., Bhojwani, D., Fry, T. J., Martin, P. L., … Wayne, A. S. (2021). Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction. Pediatr Blood Cancer, 68(1), e28574. https://doi.org/10.1002/pbc.28574

Shah, Nirali N., Jennifer Schneiderman, Denison Kuruvilla, Deepa Bhojwani, Terry J. Fry, Paul L. Martin, Kirk R. Schultz, et al. “Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction.” Pediatr Blood Cancer 68, no. 1 (January 2021): e28574. https://doi.org/10.1002/pbc.28574.

Shah NN, Schneiderman J, Kuruvilla D, Bhojwani D, Fry TJ, Martin PL, et al. Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction. Pediatr Blood Cancer. 2021 Jan;68(1):e28574.

Shah, Nirali N., et al. “Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction.” Pediatr Blood Cancer, vol. 68, no. 1, Jan. 2021, p. e28574. Pubmed, doi:10.1002/pbc.28574.

Shah NN, Schneiderman J, Kuruvilla D, Bhojwani D, Fry TJ, Martin PL, Schultz KR, Silverman LB, Whitlock JA, Wood B, Vainshtein I, Adams A, Confer D, Pulsipher MA, Chaudhury S, Wayne AS. Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction. Pediatr Blood Cancer. 2021 Jan;68(1):e28574.